AAAAI: Omalizumab Superior to Placebo for Those With Multiple Food Allergies

MONDAY, Feb. 26, 2024 -- Omalizumab treatment for 16 weeks is superior to placebo for increasing the reaction threshold for peanut and other food allergens among persons with multiple food allergies, according to a study published online Feb. 25 in...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news